Associated Press/Photo by Mark Lambie/The El Paso Times

COVID-19 cases and deaths rise across U.S.

by Kyle Ziemnick
Posted 10/26/20, 05:01 pm

El Paso, Texas, converted part of its convention center into a hospital and on Sunday imposed a 10 p.m. to 5 a.m. curfew carrying a fine of up to $500 to slow the spread of the coronavirus. The United States’ average daily COVID-19 death count rose by 10 percent over two weeks, reaching 794 on Sunday.

Read more

Eva Marie Uzcategui/Bloomberg via Getty Images

Lending an arm to end COVID-19

Health | Trials and volunteers assist pharmaceutical companies as they race to make a safe coronavirus vaccine for the public
by Katie Gaultney
Posted 10/16/20, 03:26 pm

As a doctor of nursing practice, Tara Cavazos is very comfortable being the one giving the shots. But last month, she found herself in the role of “patient” as a participant in Pfizer’s COVID-19 vaccine trial in Dallas. 

In the trial, participants don’t know whether they’ve received the vaccine or a placebo—a hypertonic saline solution. Cavazos reported feeling “some discomfort” during her first injection, along with residual pain in her bicep. 

“It felt different than a typical flu shot or a tetanus vaccine,” she said. 

Read more


Vaccine tests and delays

Medicine | The road to a “safe and effective” coronavirus vaccine—and who will get it first
by Charles Horton, M.D.
Posted 10/14/20, 06:50 pm

Federal regulators last week issued new safety guidance for pharmaceutical companies developing coronavirus vaccines. The Food and Drug Administration stated that researchers would need to observe volunteers participating in final-stage vaccine testing for at least two months after giving them their last shot. The two-month period is meant to ensure that volunteers do not develop serious reactions to the vaccines. 

Read more